^
    7ms
    Press release Biocartis group NV: Biocartis honors breast cancer awareness month with launch of breast cancer portfolio (Biocartis Press Release)
    "Biocartis Group NV...announces the launch of the new Breast Cancer Portfolio during the Breast Cancer Awareness month: the Idylla™ PIK3CA-AKT1 Mutation Assay and, in collaboration with APIS Assay Technologies (APIS), the APIS Breast Cancer Subtyping Kit and the APIS ESR1 Mutations Kit."
    Licensing / partnership • Launch
    |
    APIS Breast Cancer Subtyping Kit • APIS ESR1 Mutations Kit • Idylla™ PIK3CA-AKT1 Mutation Assay